Maggie completed her undergraduate studies at Yale University, where she double majored in molecular, cellular, and developmental biology and economics. She then moved to the Bay Area for medical school at Stanford, where she became interested in clinical research and clinical trial development. Upon completion of medical school, she stayed at Stanford for residency training, where her research interests focused on clinical outcomes of immune checkpoint inhibitors and circulating tumor free DNA as a biomarker for disease recurrence and treatment response. During fellowship, she aims to further her interests in clinical trial development in genitourinary cancers and soft tissue sarcoma.